Robert Paisley, MD

Dr. Robert Paisley is an accomplished physician, researcher, and entrepreneur with extensive experience in cardiac electrophysiology and general cardiology. 

Show full bio

Dr. Paisley graduated from Texas A&M University with a Bachelor of Arts in Biology and a minor in History, where he was recognized for his academic achievements by being inducted into Phi Beta Kappa, a prestigious national academic honors society.

He completed his fellowship in cardiovascular disease and subspecialty fellowship in cardiac electrophysiology at The Texas Heart Institute and Baylor College of Medicine after earning his Doctor of Medicine degree from the University of Texas Medical School at Houston and internal medicine training at Walter Reed Army Medical Center and Baylor College of Medicine.

Following medical school, Dr. Paisley began his military career as a commissioned officer in the U.S. Army Medical Corps. He completed an internship in internal medicine at Walter Reed Army Medical Center in Washington D.C. and volunteered for a combat deployment as the Battalion Surgeon for 3-509th Infantry (Airborne) at Joint Base Elmendorf-Richardson, Alaska.

Dr. Paisley’s awards and decorations include the Bronze Star for meritorious service while deployed to Afghanistan, the Army Commendation Medal, the Combat Medical Badge, the Parachutist Badge and the Royal Thai Army Parachutist Badge.

Dr. Paisley is committed to using his expertise in cardiac electrophysiology and cardiology to improve the lives of his patients and contribute to ongoing research in the field. His military background has taught him to be resilient and adaptable, qualities that he brings with him to his medical practice.

See Publications

Texas Heart Institute Positions

Education

  • Undergraduate:

    Texas A&M University

  • Medical School:

    University of Texas Health Science Center - Houston

  • Residency:

    Baylor College of Medicine

  • Fellowships:

    The Texas Heart Institute and Baylor College of Medicine, General Cardiology
    The Texas Heart Institute and Baylor College of Medicine, Clinical Cardiac Electrophysiology Fellowship

Publications

4862227 MDMKKD23 1 alternatives-to-animal-experimentation 10 date desc Paisley 10159 https://www.texasheart.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%225CSKUIVX%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Segar%20et%20al.%22%2C%22parsedDate%22%3A%222023-08-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BSegar%2C%20M.%20W.%2C%20Zhang%2C%20A.%2C%20%26lt%3Bstrong%26gt%3BPaisley%26lt%3B%5C%2Fstrong%26gt%3B%2C%20R.%20D.%20et%20al.%20%282023%29.%20Risk%20stratification%20in%20patients%20who%20underwent%20percutaneous%20left%20atrial%20appendage%20occlusion.%20%26lt%3Bi%26gt%3BAm%20J%20Cardiol%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B200%26lt%3B%5C%2Fi%26gt%3B%2C%2050%26%23x2013%3B56.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.amjcard.2023.05.019%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.amjcard.2023.05.019%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Risk%20stratification%20in%20patients%20who%20underwent%20percutaneous%20left%20atrial%20appendage%20occlusion%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20W.%22%2C%22lastName%22%3A%22Segar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Allan%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20D.%22%2C%22lastName%22%3A%22Paisley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anish%22%2C%22lastName%22%3A%22Badjatiya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kaleb%20D.%22%2C%22lastName%22%3A%22Lambeth%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karen%22%2C%22lastName%22%3A%22Mullins%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mehdi%22%2C%22lastName%22%3A%22Razavi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joanna%20E.%22%2C%22lastName%22%3A%22Molina-Razavi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Abdi%22%2C%22lastName%22%3A%22Rasekh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mohammad%22%2C%22lastName%22%3A%22Saeed%22%7D%5D%2C%22abstractNote%22%3A%22Left%20atrial%20appendage%20occlusion%20%28LAAO%29%20is%20effective%20in%20preventing%20thromboembolism.%20Risk%20stratification%20tools%20could%20help%20identify%20patients%20at%20risk%20for%20early%20mortality%20after%20LAAO.%20In%20this%20study%2C%20we%20validated%20and%20recalibrated%20a%20clinical%20risk%20score%20%28CRS%29%20to%20predict%20risk%20of%20all-cause%20mortality%20after%20LAAO.%20This%20study%20used%20data%20from%20patients%20who%20underwent%20LAAO%20in%20a%20single-center%2C%20tertiary%20hospital.%20A%20previously%20developed%20CRS%20using%205%20variables%20%28age%2C%20body%20mass%20index%20%5BBMI%5D%2C%20diabetes%2C%20heart%20failure%2C%20and%20estimated%20glomerular%20filtration%20rate%29%20was%20applied%20to%20each%20patient%20to%20assess%20risk%20of%20all-cause%20mortality%20at%201%20and%202%5Cu00a0years.%20The%20CRS%20was%20recalibrated%20to%20the%20present%20study%20cohort%20and%20compared%20with%20established%20atrial%20fibrillation-specific%20%28CHA2DS2-VASc%20and%20HAS-BLED%29%20and%20generalized%20%28Walter%20index%29%20risk%20scores.%20Cox%20proportional%20hazard%20models%20were%20used%20to%20assess%20the%20risk%20of%20mortality%20and%20discrimination%20was%20assessed%20by%20Harrel%20C-index.%20Among%20223%20patients%2C%20the%201-%20and%202-year%20mortality%20rates%20were%206.7%25%20and%2011.2%25%2C%20respectively.%20With%20the%20original%20CRS%2C%20only%20low%20BMI%20%28%26lt%3B23%5Cu00a0kg%5C%2Fm2%29%20was%20a%20significant%20predictor%20of%20all-cause%20mortality%20%28hazard%20ratio%20%5BHR%5D%20%5B95%25%20CI%5D%202.76%20%5B1.03%20to%207.35%5D%3B%20p%5Cu00a0%3D%5Cu00a00.04%29.%20With%20recalibration%2C%20BMI%20%26lt%3B29%5Cu00a0kg%5C%2Fm2%20and%20estimated%20glomerular%20filtration%20rate%20%26lt%3B60%5Cu00a0ml%5C%2Fmin%5C%2F1.73%5Cu00a0m2%20were%20significantly%20associated%20with%20an%20increased%20risk%20of%20death%20%28HR%20%5B95%25%20CI%5D%203.24%20%5B1.29%20to%208.13%5D%20and%202.48%20%5B1.07%20to%205.74%5D%2C%20respectively%29%2C%20with%20a%20trend%20toward%20significance%20noted%20for%20history%20of%20heart%20failure%20%28HR%20%5B95%25%20CI%5D%202.13%20%5B0.97%20to%204.67%5D%2C%20p%5Cu00a0%3D%5Cu00a00.06%29.%20Recalibration%20improved%20the%20discriminative%20ability%20of%20the%20CRS%20from%200.65%20to%200.70%20and%20significantly%20outperformed%20established%20risk%20scores%20%28CHA2DS2-VASc%5Cu00a0%3D%5Cu00a00.58%2C%20HAS-BLED%5Cu00a0%3D%5Cu00a00.55%2C%20Walter%20index%5Cu00a0%3D%5Cu00a00.62%29.%20In%20this%20single-center%2C%20observational%20study%2C%20the%20recalibrated%20CRS%20accurately%20risk%20stratified%20patients%20who%20underwent%20LAAO%20and%20significantly%20outperformed%20established%20atrial%20fibrillation-specific%20and%20generalized%20risk%20scores.%20In%20conclusion%2C%20clinical%20risk%20scores%20should%20be%20considered%20as%20an%20adjunct%20to%20standard%20of%20care%20when%20evaluating%20a%20patient%26%23039%3Bs%20candidacy%20for%20LAAO.%22%2C%22date%22%3A%222023-08-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.amjcard.2023.05.019%22%2C%22ISSN%22%3A%221879-1913%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22MQPA457U%22%2C%22DYX9DYCW%22%2C%22MDMKKD23%22%2C%22Q5SGFS6G%22%2C%22B842TXVQ%22%2C%22PCL6ADRQ%22%2C%22TU4G2TDX%22%2C%22Q46ISS7S%22%2C%224U5B8N6T%22%5D%2C%22dateModified%22%3A%222023-07-21T19%3A10%3A02Z%22%7D%7D%2C%7B%22key%22%3A%22HLIIZQG7%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Paisley%20et%20al.%22%2C%22parsedDate%22%3A%222022-04%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bstrong%26gt%3BPaisley%26lt%3B%5C%2Fstrong%26gt%3B%2C%20R.%20D.%2C%20Tan%2C%20M.%20C.%2C%20Razavi%2C%20M.%20et%20al.%20%282022%29.%20Iatrogenic%20macroreentry%20arising%20after%20transseptal%20puncture%3A%20A%20case%20series.%20%26lt%3Bi%26gt%3BHeartRhythm%20Case%20Rep%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B8%26lt%3B%5C%2Fi%26gt%3B%2C%20270%26%23x2013%3B274.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.hrcr.2022.01.013%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.hrcr.2022.01.013%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Iatrogenic%20macroreentry%20arising%20after%20transseptal%20puncture%3A%20A%20case%20series%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20Douglas%22%2C%22lastName%22%3A%22Paisley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20Charles%22%2C%22lastName%22%3A%22Tan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mehdi%22%2C%22lastName%22%3A%22Razavi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mohammad%22%2C%22lastName%22%3A%22Saeed%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22Apr%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.hrcr.2022.01.013%22%2C%22ISSN%22%3A%222214-0271%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22MQPA457U%22%2C%22MDMKKD23%22%2C%22QDP2QXTS%22%2C%22V4E2TPM3%22%2C%22X2D36SJL%22%5D%2C%22dateModified%22%3A%222022-05-27T18%3A47%3A56Z%22%7D%7D%2C%7B%22key%22%3A%22A6Q5D5I3%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Angelini%20et%20al.%22%2C%22parsedDate%22%3A%222020-04-21%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BAngelini%2C%20P.%2C%20Muthupillai%2C%20R.%2C%20Cheong%2C%20B.%20et%20al.%20%282020%29.%20We%20have%20plenty%20of%20reasons%20to%20propose%20new%2C%20updated%20policies%20for%20preventing%20sudden%20cardiac%20death%20in%20young%20athletes.%20%26lt%3Bi%26gt%3BJ%20Am%20Heart%20Assoc%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B9%26lt%3B%5C%2Fi%26gt%3B%2C%20e014368.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1161%5C%2FJAHA.119.014368%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1161%5C%2FJAHA.119.014368%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22We%20have%20plenty%20of%20reasons%20to%20propose%20new%2C%20updated%20policies%20for%20preventing%20sudden%20cardiac%20death%20in%20young%20athletes%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paolo%22%2C%22lastName%22%3A%22Angelini%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raja%22%2C%22lastName%22%3A%22Muthupillai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%22%2C%22lastName%22%3A%22Cheong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%22%2C%22lastName%22%3A%22Paisley%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22Apr%2021%2C%202020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1161%5C%2FJAHA.119.014368%22%2C%22ISSN%22%3A%222047-9980%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22UJCYSTVM%22%2C%22CXMKC5YW%22%2C%22EA6QZY69%22%2C%22MDMKKD23%22%2C%228PULYTSK%22%2C%22X2D36SJL%22%5D%2C%22dateModified%22%3A%222020-05-07T20%3A36%3A06Z%22%7D%7D%2C%7B%22key%22%3A%228MAXQ4MB%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Mitchell%20et%20al.%22%2C%22parsedDate%22%3A%222018-12-25%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BMitchell%2C%20J.%20D.%2C%20Fergestrom%2C%20N.%2C%20Gage%2C%20B.%20F.%20et%20al.%20%282018%29.%20Impact%20of%20statins%20on%20cardiovascular%20outcomes%20following%20coronary%20artery%20calcium%20scoring.%20%26lt%3Bi%26gt%3BJ%20Am%20Coll%20Cardiol%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B72%26lt%3B%5C%2Fi%26gt%3B%2C%203233%26%23x2013%3B3242.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jacc.2018.09.051%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jacc.2018.09.051%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Impact%20of%20statins%20on%20cardiovascular%20outcomes%20following%20coronary%20artery%20calcium%20scoring%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joshua%20D.%22%2C%22lastName%22%3A%22Mitchell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicole%22%2C%22lastName%22%3A%22Fergestrom%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brian%20F.%22%2C%22lastName%22%3A%22Gage%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%22%2C%22lastName%22%3A%22Paisley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%22%2C%22lastName%22%3A%22Moon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%22%2C%22lastName%22%3A%22Novak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Cheezum%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leslee%20J.%22%2C%22lastName%22%3A%22Shaw%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Todd%20C.%22%2C%22lastName%22%3A%22Villines%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Compared%20with%20traditional%20risk%20factors%2C%20coronary%20artery%20calcium%20%28CAC%29%20scores%20improve%20prognostic%20accuracy%5Cu00a0for%20atherosclerotic%20cardiovascular%20disease%20%28ASCVD%29%20outcomes.%20However%2C%20the%20relative%20impact%20of%20statins%20on%20ASCVD%20outcomes%20stratified%20by%20CAC%20scores%20is%20unknown.%5CnOBJECTIVES%3A%20The%20authors%20sought%20to%20determine%20whether%20CAC%20can%20identify%20patients%20most%20likely%20to%20benefit%20from%20statin%20treatment.%5CnMETHODS%3A%20The%20authors%20identified%20consecutive%20subjects%20without%20pre-existing%20ASCVD%20or%20malignancy%20who%20underwent%20CAC%20scoring%20from%202002%20to%202009%20at%20Walter%20Reed%20Army%20Medical%20Center.%20The%20primary%20outcome%20was%20first%20major%20adverse%20cardiovascular%20event%20%28MACE%29%2C%20a%20composite%20of%20acute%20myocardial%20infarction%2C%20stroke%2C%20and%20cardiovascular%20death.%20The%20effect%20of%20statin%20therapy%20on%20outcomes%20was%20analyzed%20stratified%20by%20CAC%20presence%20and%20severity%2C%20after%20adjusting%20for%20baseline%20comorbidities%20with%20inverse%20probability%20of%20treatment%20weights%20based%20on%20propensity%20scores.%5CnRESULTS%3A%20A%20total%20of%2013%2C644%20patients%20%28mean%20age%2050%20years%3B%2071%25%20men%29%20were%20followed%20for%20a%20median%20of%209.4%20years.%20Comparing%20patients%20with%20and%20without%20statin%20exposure%2C%20statin%20therapy%20was%20associated%20with%20reduced%20risk%20of%20MACE%20in%20patients%20with%20CAC%20%28adjusted%20subhazard%20ratio%3A%200.76%3B%2095%25%20confidence%20interval%3A%200.60%20to%200.95%3B%20p%5Cu00a0%3D%5Cu00a00.015%29%2C%20but%20not%20in%20patients%20without%20CAC%20%28adjusted%20subhazard%20ratio%3A%201.00%3B%2095%25%20confidence%20interval%3A%200.79%20to%201.27%3B%20p%5Cu00a0%3D%5Cu00a00.99%29.%20The%20effect%20of%20statin%20use%20on%20MACE%20was%20significantly%20related%20to%20the%20severity%20of%20CAC%20%28p%5Cu00a0%26lt%3B%200.0001%20for%20interaction%29%2C%20with%20the%20number%20needed%20to%20treat%20to%20prevent%201%5Cu00a0initial%20MACE%20outcome%20over%2010%20years%20ranging%20from%20100%20%28CAC%201%20to%20100%29%20to%2012%20%28CAC%20%26gt%3B100%29.%5CnCONCLUSIONS%3A%20In%20a%20largescale%20cohort%20without%20baseline%20ASCVD%2C%20the%20presence%20and%20severity%20of%20CAC%20identified%20patients%20most%20likely%20to%20benefit%20from%20statins%20for%20the%20primary%20prevention%20of%20cardiovascular%20diseases.%22%2C%22date%22%3A%22Dec%2025%2C%202018%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jacc.2018.09.051%22%2C%22ISSN%22%3A%221558-3597%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22MDMKKD23%22%2C%22X2D36SJL%22%5D%2C%22dateModified%22%3A%222020-10-07T21%3A39%3A31Z%22%7D%7D%2C%7B%22key%22%3A%22UR5S4338%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Mitchell%20et%20al.%22%2C%22parsedDate%22%3A%222017-11-10%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BMitchell%2C%20J.%20D.%2C%20%26lt%3Bstrong%26gt%3BPaisley%26lt%3B%5C%2Fstrong%26gt%3B%2C%20R.%2C%20Moon%2C%20P.%20et%20al.%20%282017%29.%20Coronary%20artery%20calcium%20and%20long-term%26%23xA0%3Brisk%20of%20death%2C%20myocardial%26%23xA0%3Binfarction%2C%20and%20stroke%3A%20The%20Walter%20Reed%20Cohort%20Study.%20%26lt%3Bi%26gt%3BJACC%20Cardiovasc%20Imaging%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jcmg.2017.09.003%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jcmg.2017.09.003%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Coronary%20artery%20calcium%20and%20long-term%5Cu00a0risk%20of%20death%2C%20myocardial%5Cu00a0infarction%2C%20and%20stroke%3A%20The%20Walter%20Reed%20Cohort%20Study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joshua%20D.%22%2C%22lastName%22%3A%22Mitchell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%22%2C%22lastName%22%3A%22Paisley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%22%2C%22lastName%22%3A%22Moon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%22%2C%22lastName%22%3A%22Novak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Todd%20C.%22%2C%22lastName%22%3A%22Villines%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVES%3A%20This%20study%20aimed%20to%20assess%20the%20long-term%20risk%20of%20death%20and%20atherosclerotic%20cardiovascular%20disease%20%28ASCVD%29%5Cu00a0outcomes%2C%20including%20stroke%2C%20in%20a%20real-world%20cohort%20that%20underwent%20coronary%20artery%20calcium%20%28CAC%29%20scoring.%5CnBACKGROUND%3A%20Large-scale%2C%20long-term%20studies%20assessing%20the%20independent%20relationship%20of%20CAC%20for%20prediction%20of%5Cu00a0ASCVD%5Cu00a0events%2C%20to%20include%20stroke%2C%20in%20young%2C%20low-risk%20patients%20are%20uncommon%20outside%20of%20the%20clinical%20trial%20setting.%5CnMETHODS%3A%20A%20total%20of%2023%2C637%20consecutive%20subjects%20without%20ASCVD%20who%20underwent%20CAC%20scoring%20from%201997%20to%202009%20were%20studied.%20Subjects%20were%20assessed%20for%20myocardial%20infarction%20%28MI%29%2C%20stroke%2C%20major%20adverse%20cardiovascular%20events%20%28MACE%29%20%28e.g.%2C%5Cu00a0MI%2C%20stroke%2C%20or%20cardiovascular%20death%29%2C%20and%20all-cause%20mortality.%20Outcomes%20were%20extracted%20from%20the%20Military%20Data%20Repository%20and%20the%20National%20Death%20Index%20and%20assessed%20using%20Cox%20proportional%20hazards%20models%2C%20controlling%20for%20baseline%20risk%20factors%2C%20atrial%20fibrillation%2C%20and%20competing%20mortality.%5CnRESULTS%3A%20Patients%20%28mean%20age%2050.0%20%5Cu00b1%208.5%20years%29%20were%20followed%20over%20a%20median%20of%2011.4%20years.%20The%20relative%20adjusted%20subhazard%20ratio%20%28aSHR%29%20for%20CAC%201%20to%20100%2C%20101%20to%20400%2C%20and%20%26gt%3B400%20was%202.2%2C%203.8%2C%20and%205.9%20for%20MI%3B%201.2%2C%201.4%2C%20and%201.9%20for%20stroke%3B%201.4%2C%202.0%2C%20and%202.8%20for%20MACE%3B%20and%201.2%2C%201.5%20and%202.1%20for%20death%20%28p%5Cu00a0%26lt%3B%200.0001%29.%20The%20addition%20of%20CAC%20score%20to%20risk%20factors%20significantly%20improved%20the%20prognostic%20accuracy%20for%20all%20outcomes%20by%20the%20likelihood%20ratio%20test.%20Area%20under%20the%20curve%20increased%20from%200.658%20to%200.738%20for%20MI%2C%200.703%20to%200.704%20for%20stroke%2C%200.685%20to%200.705%20for%20MACE%2C%20and%200.759%20to%200.767%20for%20mortality.%20Among%20subjects%20without%20traditional%20risk%20factors%20%28n%5Cu00a0%3D%206%2C208%3B%20mean%20age%2043.8%20%5Cu00b1%204.4%20years%29%2C%20the%20presence%20of%20any%20CAC%20%28%26gt%3B0%3B%20n%5Cu00a0%3D%20848%29%20was%20associated%20with%20an%20increased%20risk%20of%20MACE%20%28aSHR%3A%201.67%3B%2095%25%20confidence%20interval%3A%201.16%20to%202.39%29.%5CnCONCLUSIONS%3A%20CAC%20scoring%20significantly%20improved%20long-term%20prognostic%20accuracy%20for%20MACE%20events%20and%20mortality%2C%20irrespective%20of%20age%20and%20risk%20factors.%20These%20results%20support%20CAC%20screening%20for%20improving%20individual%20ASCVD%20risk%20assessment%20and%20prevention%20in%20low-risk%2C%20young%20adults.%22%2C%22date%22%3A%22Nov%2010%2C%202017%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jcmg.2017.09.003%22%2C%22ISSN%22%3A%221876-7591%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22MDMKKD23%22%2C%22X2D36SJL%22%5D%2C%22dateModified%22%3A%222020-10-07T22%3A49%3A09Z%22%7D%7D%2C%7B%22key%22%3A%22JNDA7GFG%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Paisley%22%2C%22parsedDate%22%3A%222015-04%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bstrong%26gt%3BPaisley%26lt%3B%5C%2Fstrong%26gt%3B%2C%20R.%20D.%20%282015%29.%20Nutritional%20and%20sports%20supplement%20use%20among%20deployed%20U.S.%20Army%20soldiers%20in%20a%20remote%2C%20austere%20combat%20outpost%20in%20eastern%20Afghanistan.%20%26lt%3Bi%26gt%3BMil%20Med%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B180%26lt%3B%5C%2Fi%26gt%3B%2C%20391%26%23x2013%3B401.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.7205%5C%2FMILMED-D-14-00334%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.7205%5C%2FMILMED-D-14-00334%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Nutritional%20and%20sports%20supplement%20use%20among%20deployed%20U.S.%20Army%20soldiers%20in%20a%20remote%2C%20austere%20combat%20outpost%20in%20eastern%20Afghanistan%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20D.%22%2C%22lastName%22%3A%22Paisley%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Nutritional%20and%20sports%20supplements%20are%20commonly%20used%20by%20soldiers%2C%20with%20uncertain%20implications%20for%20health%20and%20mission%20readiness.%5CnMETHODS%3A%20An%20anonymous%20survey%20was%20conducted%20of%20a%20company%20of%20U.S.%20Army%20paratroopers%20deployed%20to%20eastern%20Afghanistan%20between%20December%202011%20and%20October%202012.%20Survey%20questions%20covered%20supplements%20used%2C%20duration%20of%20use%2C%20adverse%20effects%2C%20and%20medication%20interactions.%20Exercise%20habits%2C%20goals%20for%20exercise%20and%20supplement%20use%2C%20and%20information%20and%20acquisition%20sources%20were%20also%20queried.%5CnRESULTS%3A%20Out%20of%20112%20surveys%20distributed%2C%20100%20completed%20surveys%20were%20returned.%2077%20respondents%20reported%20using%20at%20least%20one%20supplement%20during%20deployment.%20On%20average%2C%202.5%20supplements%20were%20used%20per%20individual%20surveyed.%20Nine%20respondents%20reported%20adverse%20effects%20of%20supplement%20use.%20No%20respondents%20reported%20serious%20complications%20of%20supplement%20use%2C%20drug%20interactions%2C%20or%20seeking%20medical%20care%20for%20supplement%20adverse%20effects.%20The%20Internet%20was%20the%20most%20frequently%20reported%20source%20of%20information%20on%20supplement%20use.%20Most%20frequently%2C%20supplements%20were%20acquired%20by%20Internet%20mail%20order.%5CnCONCLUSIONS%20AND%20RELEVANCE%3A%20Supplement%20use%20occurs%20during%20deployment%20among%20paratroopers%20at%20a%20higher%20rate%20than%20reported%20in%20garrison%2C%20despite%20their%20remote%20and%20austere%20deployed%20location.%20These%20findings%20have%20profound%20implications%20for%20military%20health%20care%20providers%20and%20policy%20makers%20considering%20the%20health%20of%20deployed%20combat%20soldiers.%22%2C%22date%22%3A%222015-04%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.7205%5C%2FMILMED-D-14-00334%22%2C%22ISSN%22%3A%221930-613X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22MDMKKD23%22%5D%2C%22dateModified%22%3A%222023-06-21T13%3A50%3A58Z%22%7D%7D%2C%7B%22key%22%3A%22MRZFK8WZ%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Shah%20et%20al.%22%2C%22parsedDate%22%3A%222013-06%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BShah%2C%20N.%20R.%2C%20Bieniarz%2C%20M.%20C.%2C%20Basra%2C%20S.%20S.%20et%20al.%20%282013%29.%20Serum%20biomarkers%20in%20severe%20refractory%20cardiogenic%20shock.%20%26lt%3Bi%26gt%3BJACC%20Heart%20Fail%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B1%26lt%3B%5C%2Fi%26gt%3B%2C%20200%26%23x2013%3B206.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jchf.2013.03.002%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jchf.2013.03.002%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Serum%20biomarkers%20in%20severe%20refractory%20cardiogenic%20shock%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nishant%20R.%22%2C%22lastName%22%3A%22Shah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20C.%22%2C%22lastName%22%3A%22Bieniarz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sukhdeep%20S.%22%2C%22lastName%22%3A%22Basra%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20D.%22%2C%22lastName%22%3A%22Paisley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pranav%22%2C%22lastName%22%3A%22Loyalka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Igor%20D.%22%2C%22lastName%22%3A%22Gregoric%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Douglas%20L.%22%2C%22lastName%22%3A%22Mann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Biswajit%22%2C%22lastName%22%3A%22Kar%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVES%3A%20The%20aim%20of%20this%20study%20was%20to%20characterize%20levels%20of%20serum%20biomarkers%20in%20patients%20with%20severe%20refractory%20cardiogenic%20shock%20%28SRCS%29%20and%20to%20document%20temporal%20changes%20in%20these%20levels%20during%20restoration%20of%20circulation.%5CnBACKGROUND%3A%20Patients%20with%20SRCS%20have%20been%20challenging%20to%20study%20because%20of%20their%20rapidly%20changing%20clinical%20condition%20while%20undergoing%20multiple%20simultaneous%20interventions.%5CnMETHODS%3A%20Twenty-one%20patients%20with%20SRCS%20received%20circulatory%20support%20via%20a%20percutaneously%20implanted%20ventricular%20assist%20device%20%28PVAD%29.%20Serum%20samples%20obtained%20prior%20to%20PVAD%20support%20initiation%2C%20at%2024%20h%20of%20PVAD%20support%2C%20and%20at%207%20days%20of%20PVAD%20support%20were%20assayed%20for%20B-type%20natriuretic%20peptide%20%28BNP%29%2C%20high-sensitivity%20C-reactive%20protein%20%28hsCRP%29%2C%20soluble%20tumor%20necrosis%20factor%20receptor-1%20%28sTNFR1%29%2C%20soluble%20Fas%20%28sFas%29%2C%20soluble%20Fas%20ligand%20%28sFasL%29%2C%20endothelin-1%2C%20and%20procollagen%20III%20N-terminal%20peptide%20%28PIIINP%29.%20Baseline%20biomarker%20levels%20were%20qualitatively%20compared%20to%20reference%20values%3B%20levels%20at%2024%20h%20of%20PVAD%20support%20and%20at%207%20days%20of%20PVAD%20support%20were%20compared%20to%20baseline%20using%202-tailed%20Wilcoxon%20matched%20pair%20signed%20rank%20tests%20with%20Bonferroni%20correction%20for%20multiple%20comparisons.%5CnRESULTS%3A%20These%20patients%20with%20SRCS%20had%20elevated%20serum%20levels%20of%20BNP%2C%20hsCRP%2C%20sTNFR1%2C%20endothelin-1%2C%20and%20PIIINP.%20Ventricular%20unloading%20and%20restoration%20of%20circulation%20via%20PVAD%20support%20in%20patients%20with%20SRCS%20were%20associated%20with%20reductions%20in%20serum%20BNP%2C%20sFas%2C%20and%20endothelin-1%20levels%20and%20increases%20in%20serum%20sFasL%20and%20PIIINP%20levels.%5CnCONCLUSIONS%3A%20This%20study%20characterizes%20several%20important%20baseline%20serum%20biomarker%20levels%20in%20patients%20with%20SRCS%20and%20introduces%20a%20novel%20PVAD-based%20protocol%20with%20the%20potential%20to%20%26quot%3Breverse%26quot%3B-model%20the%20pathophysiology%20of%20cardiogenic%20shock.%22%2C%22date%22%3A%22Jun%202013%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jchf.2013.03.002%22%2C%22ISSN%22%3A%222213-1787%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22MDMKKD23%22%2C%22X2D36SJL%22%5D%2C%22dateModified%22%3A%222018-09-05T17%3A34%3A09Z%22%7D%7D%2C%7B%22key%22%3A%22S6DBGBGT%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Paisley%20et%20al.%22%2C%22parsedDate%22%3A%222012-02%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bstrong%26gt%3BPaisley%26lt%3B%5C%2Fstrong%26gt%3B%2C%20R.%20D.%2C%20Blaylock%2C%20J.%20and%20Hartzell%2C%20J.%20D.%20%282012%29.%20Whooping%20cough%20in%20adults%3A%20an%20update%20on%20a%20reemerging%20infection.%20%26lt%3Bi%26gt%3BAm%20J%20Med%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B125%26lt%3B%5C%2Fi%26gt%3B%2C%20141%26%23x2013%3B143.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.amjmed.2011.05.008%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.amjmed.2011.05.008%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Whooping%20cough%20in%20adults%3A%20an%20update%20on%20a%20reemerging%20infection%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20D.%22%2C%22lastName%22%3A%22Paisley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jason%22%2C%22lastName%22%3A%22Blaylock%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joshua%20D.%22%2C%22lastName%22%3A%22Hartzell%22%7D%5D%2C%22abstractNote%22%3A%22Pertussis%2C%20or%20whooping%20cough%2C%20which%20is%20commonly%20thought%20of%20as%20a%20pediatric%20illness%2C%20is%20an%20underappreciated%20adult%20pathogen.%20Recent%20outbreaks%20highlight%20the%20significance%20of%20pertussis%20in%20adults%20and%20the%20risk%20of%20transmission%20to%20at-risk%20infants%20who%20are%20most%20susceptible%20to%20complications%2C%20including%20death.%20This%20article%20describes%20the%20recent%20epidemiologic%20shifts%20and%20reviews%20the%20clinical%20presentation%2C%20diagnosis%2C%20and%20treatment%20of%20pertussis.%20New%20vaccination%20recommendations%20by%20the%20Advisory%20Committee%20on%20Immunization%20Practices%20in%20response%20to%20recent%20outbreaks%20and%20infant%20deaths%20are%20highlighted.%22%2C%22date%22%3A%222012-02%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.amjmed.2011.05.008%22%2C%22ISSN%22%3A%221555-7162%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22MDMKKD23%22%5D%2C%22dateModified%22%3A%222023-06-21T13%3A51%3A13Z%22%7D%7D%2C%7B%22key%22%3A%22CJ7R2WG5%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Paisley%20et%20al.%22%2C%22parsedDate%22%3A%222009%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bstrong%26gt%3BPaisley%26lt%3B%5C%2Fstrong%26gt%3B%2C%20R.%20D.%2C%20Arora%2C%20H.%20S.%2C%20Nazeri%2C%20A.%20et%20al.%20%282009%29.%20Migraine%20and%20vasodepressor%20syncope%20in%20a%20large%20family.%20%26lt%3Bi%26gt%3BTex%20Heart%20Inst%20J%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B36%26lt%3B%5C%2Fi%26gt%3B%2C%20468%26%23x2013%3B469%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Migraine%20and%20vasodepressor%20syncope%20in%20a%20large%20family%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20D.%22%2C%22lastName%22%3A%22Paisley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Harvinder%20S.%22%2C%22lastName%22%3A%22Arora%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alireza%22%2C%22lastName%22%3A%22Nazeri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ali%22%2C%22lastName%22%3A%22Massumi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mehdi%22%2C%22lastName%22%3A%22Razavi%22%7D%5D%2C%22abstractNote%22%3A%22We%20evaluated%20a%2047-year-old%20woman%20for%20recurrent%20migraine%20and%20syncope.%20The%20patient%20had%207%20children%20%28not%20examined%20by%20the%20authors%29%2C%20all%20of%20whom%20also%20experienced%20migraine%20and%20syncope.%20The%20patient%26%23039%3Bs%20father%2C%20now%20deceased%2C%20had%20reportedly%20experienced%20migraine%20and%20episodes%20of%20feeling%20faint.%20All%205%20of%20the%20patient%26%23039%3Bs%20siblings%20reported%20migraine%2C%20and%204%20of%20the%205%20reported%20syncope.%20The%20case%20of%20our%20patient%2C%20which%20we%20discuss%20herein%2C%20suggests%20a%20genetic%20link%20between%20these%202%20conditions%2C%20both%20of%20which%20include%20vascular%20dysregulation%20in%20their%20pathogenesis.%20To%20our%20knowledge%2C%20the%20medical%20literature%20contains%20no%20previous%20description%20of%20familial%20associations%20of%20combined%20migraine%20and%20syncope.%22%2C%22date%22%3A%222009%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%221526-6702%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22MQPA457U%22%2C%225RXGKSVK%22%2C%22MDMKKD23%22%2C%22X2D36SJL%22%5D%2C%22dateModified%22%3A%222022-02-14T21%3A40%3A36Z%22%7D%7D%5D%7D
Segar, M. W., Zhang, A., Paisley, R. D. et al. (2023). Risk stratification in patients who underwent percutaneous left atrial appendage occlusion. Am J Cardiol 200, 50–56. https://doi.org/10.1016/j.amjcard.2023.05.019.
Paisley, R. D., Tan, M. C., Razavi, M. et al. (2022). Iatrogenic macroreentry arising after transseptal puncture: A case series. HeartRhythm Case Rep 8, 270–274. https://doi.org/10.1016/j.hrcr.2022.01.013.
Angelini, P., Muthupillai, R., Cheong, B. et al. (2020). We have plenty of reasons to propose new, updated policies for preventing sudden cardiac death in young athletes. J Am Heart Assoc 9, e014368. https://doi.org/10.1161/JAHA.119.014368.
Mitchell, J. D., Fergestrom, N., Gage, B. F. et al. (2018). Impact of statins on cardiovascular outcomes following coronary artery calcium scoring. J Am Coll Cardiol 72, 3233–3242. https://doi.org/10.1016/j.jacc.2018.09.051.
Mitchell, J. D., Paisley, R., Moon, P. et al. (2017). Coronary artery calcium and long-term risk of death, myocardial infarction, and stroke: The Walter Reed Cohort Study. JACC Cardiovasc Imaging. https://doi.org/10.1016/j.jcmg.2017.09.003.
Paisley, R. D. (2015). Nutritional and sports supplement use among deployed U.S. Army soldiers in a remote, austere combat outpost in eastern Afghanistan. Mil Med 180, 391–401. https://doi.org/10.7205/MILMED-D-14-00334.
Shah, N. R., Bieniarz, M. C., Basra, S. S. et al. (2013). Serum biomarkers in severe refractory cardiogenic shock. JACC Heart Fail 1, 200–206. https://doi.org/10.1016/j.jchf.2013.03.002.
Paisley, R. D., Blaylock, J. and Hartzell, J. D. (2012). Whooping cough in adults: an update on a reemerging infection. Am J Med 125, 141–143. https://doi.org/10.1016/j.amjmed.2011.05.008.
Paisley, R. D., Arora, H. S., Nazeri, A. et al. (2009). Migraine and vasodepressor syncope in a large family. Tex Heart Inst J 36, 468–469

Recent News

See All

Cardiac Electrophysiologist Dr. Robert Paisley Joins The Texas Heart Institute Center for Cardiovascular Care

HOUSTON (June 17, 2023) — The Texas Heart Institute Center for Cardiovascular Care is pleased to welcome Robert D. Paisley, MD,...

Read more

THI Doctors First to Describe an Uncommon Cause for Atypical Flutter

THI’s Clinical Cardiac Electrophysiology Research Team Discovers a Pattern of Macroreentrant Atrial Flutter Arising in Patients Who Underwent Transseptal Puncture...

Read more

A Remarkable Match — THI Welcomes New Cardiology Fellows

The THI Cardiology Fellowship program continues to recruit some of the best applicants in the nation. We had an outstanding...

Read more